MedPath

Ehave, Inc.

Ownership
-
Employees
-
Market Cap
-
Website

An EEG Study of Intravenous Ketamine for Major Depression Disorder

Phase 4
Conditions
Major Depressive Disorder
Interventions
First Posted Date
2022-08-18
Last Posted Date
2022-08-22
Lead Sponsor
Ehave Inc.
Target Recruit Count
35
Registration Number
NCT05506462
© Copyright 2025. All Rights Reserved by MedPath